S

Shanghai OPM Biosciences Co Ltd
SSE:688293

Watchlist Manager
Shanghai OPM Biosciences Co Ltd
SSE:688293
Watchlist
Price: 53.93 CNY -1.77% Market Closed
Market Cap: ¥6.1B

Operating Margin

5.4%
Current
Declining
by 7.8%
vs 3-y average of 13.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.4%
=
Operating Income
¥18m
/
Revenue
¥331.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.4%
=
Operating Income
¥18m
/
Revenue
¥331.4m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Shanghai OPM Biosciences Co Ltd
SSE:688293
6.3B CNY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
388.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

In line with most companies in China
Percentile
55th
Based on 8 544 companies
55th percentile
5.4%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Shanghai OPM Biosciences Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Biotechnology

Shanghai OPM Biosciences Co. Ltd. engages in the cell culture products and services. The company is headquartered in Shanghai, Shanghai and currently employs 261 full-time employees. The company went IPO on 2022-09-02. The firm's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The firm's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The firm conducts businesses both in the domestic market and overseas markets.

Intrinsic Value
37.36 CNY
Overvaluation 31%
Intrinsic Value
Price
S
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.4%
=
Operating Income
¥18m
/
Revenue
¥331.4m
What is Shanghai OPM Biosciences Co Ltd's current Operating Margin?

The current Operating Margin for Shanghai OPM Biosciences Co Ltd is 5.4%, which is below its 3-year median of 13.2%.

How has Operating Margin changed over time?

Over the last 3 years, Shanghai OPM Biosciences Co Ltd’s Operating Margin has decreased from 36.5% to 5.4%. During this period, it reached a low of -0.3% on Mar 31, 2025 and a high of 36.5% on May 30, 2022.

Back to Top